| Literature DB >> 31383941 |
Emma Short1,2, Laura E Thomas3, Alice Davies3, Alice Bolton3, Julie Maynard3, Peter Giles3, Matthew Mort3, Claudia Consoli3, Iris Egner3, Hala Jundi3, Julian R Sampson3.
Abstract
Familial adenomatous polyposis (FAP) is characterised by the development of hundreds to thousands of colorectal adenomas and results from inherited or somatic mosaic variants in the APC gene. Index patients with suspected FAP are usually investigated by APC coding region sequence and dosage analysis in a clinical diagnostic setting. The identification of an APC variant which is predicted to alter protein function enables predictive genetic testing to guide the management of family members. This report describes a 4-generation family with a phenotype consistent with FAP, but in which an APC variant had not been identified, despite testing. To explore this further, quantitative PCR (qPCR) was employed to assess APC transcription, demonstrating reduced levels of APC RNA. Next generation sequencing (NGS) identified the APC 5'UTR/ Exon 1 variant, c.-190 G>A, that had been reported previously in an another FAP family with APC allelic imbalance. Quantitative RNA studies and DNA sequencing of the APC promoters/ Exon 1 may be useful diagnostically for patients with suspected FAP when coding region variants cannot be identified.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31383941 PMCID: PMC6906400 DOI: 10.1038/s41431-019-0486-2
Source DB: PubMed Journal: Eur J Hum Genet ISSN: 1018-4813 Impact factor: 4.246